Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection
Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection
The purpose of this study is to evaluate, treat and follow patients with parasitic
 infections.

 People with a known or suspected parasitic infection who are at least 1 year old may be
 enrolled. This study does not involve any experimental treatments.

 Participants will have a physical examination and laboratory tests on blood, stool, or urine.
 Blood samples may be collected at regular intervals, but no more than 450 ml (15 ounces) of
 blood will be drawn from adults, and no more than 7 ml (1-1/2 teaspoons) per kg (2.2 pounds)
 of body weight from children, in any 6-week period. Other tests may include x-rays,
 electrocardiogram (EKG), or tissue biopsy (surgical removal of a small tissue sample),
 depending on the individual s condition.

 Patients may be offered treatment or may be referred to another study that is more
 appropriate for the problem. Any treatment provided in this study will be according to
 standard medical practice for the patient s specific medical problem. Patients responses to
 treatment will be evaluated at regularly scheduled clinic visits. The length of time between
 visits and the total duration of the study for a given individual will be determined by the
 study doctor, based on that person s medical condition.
This study is designed as a prospective study to evaluate and treat patients with parasitic
 infection. Patients with known or suspected parasitic infection will be enrolled and will be
 evaluated for the presence of a parasitic infection. Minimal studies scheduled for each visit
 will include a medical history, physical examination, routine laboratory tests and
 specialized diagnostic procedures for possible parasitic infections. Treatment plans will be
 individualized for each patient's particular condition, and the number and length of
 additional visits and diagnostic evaluations will vary accordingly. Specific treatment
 regimens will be in accordance with standard medical practice.
-  INCLUSION CRITERIA:

 Age 3 or over.

 Access to a primary medical care provider outside of the NIH.

 Ability to give written informed consent (for adults) and parental consent (for those under
 18).

 Clinical evidence suggestive of a parasitic infection.

 EXCLUSION CRITERIA:

 Less than 3 years of age.

 No evidence suggestive of a parasitic infection.

 Although pregnant or nursing women can be enrolled, they will be

 excluded from receiving treatment while pregnant or breastfeeding